Skip to main content
bill-gates-and-dean-side-by-side

Lloyd Minor and Bill Gates spoke Oct. 21 about the impact of the coronavirus pandemic on global health, the race for vaccines and therapeutics, and how to renew the faltering trust many Americans feel in science and medicine.

News

COVID-19 October 26, 2020

Bill Gates, Lloyd Minor discuss challenges of overcoming COVID-19

By Krista Conger

The Microsoft co-founder and medical school dean talked about the impact of the coronavirus pandemic on global health, the race for vaccines and therapeutics, and how to renew the faltering trust many Americans feel in science and medicine.

In 2015, on the heels of a frightening Ebola outbreak in Africa, Bill Gates gave a TED talk titled "The next outbreak? We're not ready." In it, he outlined ways in which the world was unprepared for a threat entirely different from the one his generation had grown up fearing.

"It's not missiles; it's microbes," he asserted. 

On Oct. 21, the Microsoft co-founder recalled that talk when he spoke with Lloyd Minor, MD, dean of the School of Medicine, during a StanfordMed LIVE event. They discussed the impact of the coronavirus pandemic on global health, the race for vaccines and therapeutics, and how to renew the faltering trust many Americans feel in science and medicine.

Gates' wake-up call in 2015 included remarks about the importance of ensuring the availability of antiviral medications, therapeutic antibodies and high-speed diagnostic testing to prepare for a coming pandemic. "Sadly, not that much was done," he told Minor. "The idea of 'germ games' to simulate what governments would need to do to move quickly - that didn't take place."

Gates noted that, as a result, the full scope of the COVID-19 crisis dwarfs what he had expected would happen in a pandemic.

"In 2015, I talked about a $3 trillion economic cost," he said. "In this pandemic, even though the death rate is way lower than it might have been, the economic devastation has been much greater. It will easily get to $10 [trillion] or perhaps even $15 trillion overall over the next two years before we really get completely back to normal."  

Other impacts

The pandemic has led to other problems too, including a reduction in normal vaccination rates and an increase in mental health issues, Gates said. 

"A lot of these secondary things are harder to measure than the deaths," he said. "A lot of kids will lose more than a year of schooling during this whole process." 

The breakdown of health care systems in developing countries is likely to be particularly devastating, Gates said, as food insecurity and political instability caused by the pandemic threaten governments' ability to provide medications and vaccines. "This is going to cause a much higher death toll than COVID directly," he said.

Minor and Gates also discussed the progress toward and challenges of identifying, producing and distributing a vaccine around the globe; how clinical trials could be better coordinated; how biotechnology and innovation can be accelerated in the developing world; and how the pandemic has underscored racial inequities in the United States.

"COVID-19 has laid bare a number of injustices and inequities in our own country in health and health care delivery," Minor said. "The mortality of COVID-19 among communities of color is significantly higher than in white communities. And there's the sad fact that ZIP code is a more accurate determinant of life expectancy in our country than is genetic code. How as a society do we address these problems that have been in our face for a long time but now are much more difficult to ignore than in the past because of the effects of COVID-19?"

Distrust of vaccines, shifting recommendations

Minor and Gates also addressed the public's growing distrust of vaccines and the sometimes conflicting and shifting recommendations on mask-wearing by government organizations like the Centers for Disease Control and Prevention and the World Health Organization

"When you bring people very bad news that affects them in a meaningful way, the fact is that there's going to be some pushback that you're not doing this for good reasons," Gates said, likening the response to that of people urged to change their ways due to climate change. "It's tricky, because there is uncertainty. We have to admit there's a lot we don't know. We have to be willing to admit our mistakes, and be willing to deliver bad news."

"For many of us as leaders, these have been the most challenging eight to nine months in our careers," Minor said. "What advice do you have for us in leadership roles?"

Gates chuckled. "This is a period where it's easy to work 24 hours a day. We have to say OK, it's not just for the next few months, but sadly the next few years where even in the best case we get an elimination of this disease. So you really want to work for the long haul."

Minor and Gates ended their conversation with a discussion about books. Gates recommended several, including Bijal Trivedi's Breath from Salt, which tells the story of the desperate push for new cystic fibrosis therapies from the point of view of scientists, clinicians and patients' family members; Michelle Alexander's The New Jim Crow, which explores racism in the criminal justice system; and one Gates had just begun: Fareed Zakaria's Ten Lessons for a Post-Pandemic World.

"It's a very promising title," Gates said. 

 

 

About Stanford Medicine

Stanford Medicine is an integrated academic health system comprising the Stanford School of Medicine and adult and pediatric health care delivery systems. Together, they harness the full potential of biomedicine through collaborative research, education and clinical care for patients. For more information, please visit med.stanford.edu.

Krista-Conger

Science writer

Krista Conger

Senior science writer Krista Conger, PhD ’99, covers cancer, stem cells, dermatology, developmental biology, endocrinology, pathology, hematology, radiation oncology and LGBTQ+ issues for the office. She received her undergraduate degree in biochemistry at the University of California, Berkeley and her PhD in cancer biology from Stanford University. After completing the science writing program at UC Santa Cruz, she joined the Stanford Medicine Office of Communications in 2000. She enjoys distilling complicated scientific topics into engaging prose accessible to the layperson. Over the years, she has had chronicled nascent scientific discoveries from their inception to Food and Drug Administration approval and routine clinical use — documenting the wonder and long arc of medical research. Her writing has repeatedly been recognized with awards from the Counsel for the Advancement and Support of Education and the Association of American Medical Colleges. She is a member of the National Academy of Science Writers and a certified science editor through the Board of Editors in the Life Sciences. In her spare time, she enjoys textile arts, experimenting with new recipes and hiking in beautiful northwestern Montana, where she was raised and now lives.